[1] |
HUANG WJ,HUANG JH,LIU QX,et al.Neutrophil-lymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy[J].Clin Endocrinol,2015,82(2):229. |
[2] |
冯然,刘涛,刘静芹.中性粒细胞与淋巴细胞的比值与糖尿病肾病的关系[J].山西医科大学学报,2016,47(4):356. |
[3] |
中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中国糖尿病杂志,2014,22(8):1. |
[4] |
廖勇.中国糖尿病的流行病学现状及展望[J].重庆医科大学学报,2015,40(7):1042. |
[5] |
张海华.2型糖尿病并发症的临床分析[J].中国医药指南,2015,13(8):122. |
[6] |
徐小群,钟兴,潘天荣.中性粒细胞/淋巴细胞比值与新诊断早期糖尿病肾病的相关性研究[J].中国糖尿病杂志,2016,24(24):598. |
[7] |
CIRAY H,AKSOY AH,ULU N,et al.Nephropathy,but not angiographically proven retinopathy,is associated with neutrophil to lymphocyte ratio in patients with type 2 diabetes[J].Exp Clin Endocrinol Diabetes,2015,123(5):267. |
[8] |
FUJITA T,HEMMI S,KAJIWARA M,et al.Complement-mediated chronic inflammation is associated with diabetic microvascular complication[J].Diabetes Metab Res Rev,2013,29(3):220. |
[9] |
殷俏,郭淑芹,张云良,等.2型糖尿病及其视网膜病变患者中性粒细胞/淋巴细胞比值变化和意义[J].微循环学杂志,2015,25(4):46. |
[10] |
LOU MQ,LUO P,TANG R,et al.Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients[J].BMC Endocrine Disorders,2015,15(9):1. |
[11] |
YUN KJ,MI RK,HUH JE,et al.Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes[J].J Korean Med Sci,2011,26(2):258. |
[12] |
YASSINE HN,TRENCHEVSKA O,DONG Z,et al.The association of plasma cystatin C proteoforms with diabetic chronic kidney disease[J].Proteome Sci,2016,14(7):1. |
[13] |
JAVANMARDI M,AZADI NA,AMINI S,et al.Diagnostic value of cystatin C for diagnosis of early renal damages in type 2 diabetic mellitus patients:the first expericence in Iran[J].J Res Med Sci,2015,20(6):570. |
[14] |
SUZUKI Y,MATSUSHITA K,SEIMIYA M,et al.Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with 2 diabetes[J].Clin Chem Lab Med,2012,50(10):1833. |